LTRN
Lantern Pharma Inc
1.20$
-12.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | 100.0% | – | – | – | – | – | – | |
| – | 17.0% | – | – | – | 50.9% | 4.5% | – | – | – | – | – | – | |
| – | -17.0% | – | – | – | -50.9% | -4.5% | – | – | – | – | – | – | |
| – | 1,368.8% | – | – | – | 4,241.8% | 3,242.7% | – | – | – | – | – | – | |
| – | 499.6% | – | – | – | 1,616.3% | 1,442.8% | – | – | – | – | – | – | |
| – | 1,868.4% | – | – | – | 5,858.1% | 4,743.0% | – | – | – | – | – | – | |
| – | -1,868.4% | – | – | – | -5,858.1% | -4,743.0% | – | – | – | – | – | – | |
| – | 160.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1,603.5% | – | – | – | -5,837.0% | -4,507.3% | – | – | – | – | – | – | |
| – | 0.0% | – | – | – | – | 0.0% | – | – | – | – | – | – | |
| – | -1,603.5% | – | – | – | -5,837.0% | -4,507.3% | – | – | – | – | – | – | |
| – | -1,586.5% | – | – | – | -5,786.1% | -4,502.8% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.